Diffusion MRI Tissue Activity Indicator With Noise-Resistant Estimation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for estimating biomarkers from diffusion MRI data are hindered by long calculation times, high noise levels, and low sampling, leading to unreliable and biased estimates of tissue activity, particularly in the presence of microscopic phenomena like perfusion and restricted diffusion.
Innovation Solution
A method for quantifying a novel biomarker, called TAI, using a bijective transformation of experimental data over a range of diffusion gradient values, allowing for rapid, robust, and noise-resistant estimation of tissue activity, applicable to various organs and imaging systems.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current methods for estimating biomarkers from diffusion MRI data are used, then tissue activity quantification can be obtained, but the calculation time is long and noise levels are high
Solution Approach 1:
The patent transforms the estimation problem from a discrete sampling approach to a continuous integration approach by changing the parameter representation. Instead of estimating biomarkers at discrete time points or sampling points, the method integrates the bijective transformation function continuously over the acquisition parameter b, which fundamentally changes how the calculation is performed and reduces noise sensitivity while maintaining accuracy
Solution Approach 2:
The patent replaces complex iterative estimation algorithms with a direct integration formulation. By substituting the mechanical computation process (iterative optimization) with a mathematical integration operation, the method achieves faster calculation times while improving noise resistance, as integration inherently smooths out high-frequency noise components
2Reliability
If current methods for estimating biomarkers from diffusion MRI data are used, then tissue activity quantification can be obtained, but noise levels are high leading to unreliable quantifications
Solution Approach 1:
The patent converts the harmful effect of noise into a benefit by using integration over the acquisition parameter b. The integration operation naturally acts as a low-pass filter, transforming high-frequency noise into low-frequency components that can be more easily managed. The bijective transformation function further enhances this effect by mapping the noisy data into a domain where the integration provides stronger noise suppression
Solution Approach 2:
The patent introduces the bijective transformation function as an intermediary between the raw diffusion MRI data and the final biomarker estimation. This intermediary transformation maps the data into a new domain where the subsequent integration operation can more effectively suppress noise while preserving the underlying tissue activity information, thereby improving reliability
3Measurement precision
If current methods for estimating biomarkers from diffusion MRI data are used, then tissue activity quantification can be obtained, but sampling is low leading to inaccurate results
Solution Approach 1:
The patent moves the estimation problem from a low-dimensional discrete sampling space to a higher-dimensional continuous integration space. By integrating over the acquisition parameter b, the method effectively adds a dimensional aspect to the estimation, allowing accurate tissue activity quantification even when the number of discrete samples is limited. The continuous integration captures information across the entire parameter range rather than relying on sparse discrete points
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The TAI biomarker provides accurate and stable tissue activity indicators with reduced calculation time and noise sensitivity, enhancing diagnostic capabilities for conditions such as cancer and cerebral vascular accidents.
Implementation Method 1
an imaging device 1 using nuclear magnetic resonance... applies a combination of high-frequency electromagnetic waves on the part of the body in question and measures the signal re-emitted by certain atoms, such as by way of non-limitative example, hydrogen for nuclear magnetic resonance imaging
Implementation Method 2
diffusion weighted imaging or DWI... make it possible to rapidly obtain valuable items of information on the movements of the water molecules within organs or tissues... diffusion of water molecules in living tissues on the basis of diffusion data
Data Source
AI summary
The invention relates to a system and method for quantifying a novel biomarker of the tissue activity of a human or animal organ. By way of preferred application, such a biomarker describes the diffusivity of biological fluids in living tissues in the form of a novel indicator of the diffusion of water molecules in living tissues on the basis of diffusion data resulting from the acquisition of a sequence of images of one or more parts of the body of an animal or human patient. Particularly resistant and stable with respect to noise present in the medical imaging signals from which the experimental data stem, the novel biomarker is relevant in a large number of applications including, inexhaustively, the analysis and/or monitoring of cancers, or the assessment of strokes.